Cervical cancer ranks as the 10th most common cancer among women in Greece and the 3rd most frequent among women aged 15 to 44. Despite being highly preventable, it continues to claim lives—especially among women without access to Pap smears and other preventive screening tools.

In Greece, around 4.6 million women aged 15 and older are at risk of developing cervical cancer. According to the Information Centre on HPV and Cancer, approximately 697 women are diagnosed each year, with 282 losing their lives to this largely preventable disease.

Pap Smears: A Simple Test, A Life-Saving Impact

The Pap smear remains one of the most effective weapons against cervical cancer. This routine test collects cells from the cervix to detect abnormalities before they develop into cancer. Early detection can mean the difference between life and death, as it allows for timely treatment and dramatically improves survival rates.

Regular Pap tests and pelvic exams can catch most cervical cancers early, significantly increasing the chances of successful treatment.

In 2018, Greece introduced national guidelines recommending HPV testing every five years for women aged 21 to 60. However, without an active invitation system, participation remains low.

HPV: The Underlying Culprit

The human papillomavirus (HPV) is the leading cause of cervical cancer. While many HPV infections resolve naturally, high-risk strains (notably types 16 and 18) are responsible for about 52.3% of invasive cervical cancer cases in Greece. These strains disrupt the body’s normal cell cycle, potentially leading to cancer if left unchecked.

Even “low-risk” HPV types, though not life-threatening, can cause genital warts, which contribute to emotional distress and discomfort.

The Numbers That Matter

  • 2.8% of women in Greece carry high-risk HPV types 16 or 18.
  • Over half of invasive cervical cancers are linked to these strains.
  • 282 women die annually from cervical cancer in Greece, despite existing preventive measures.

To turn the tide on cervical cancer, awareness, education, and access to screening are key. Women are strongly encouraged to consult healthcare providers for personalized screening schedules based on individual risk factors.